Essential Reviews in Geriatric Psychiatry
A Randomized Controlled Study of Paroxetine and Cognitive Behavioral Therapy for Late-Life Panic Disorder
Publication
, Chapter
Schwarz, CM; Holsinger, T
January 1, 2022
In this study the investigators evaluated the effectiveness of paroxetine and cognitive behavioral therapy (CBT) among individuals 60+ years in age with a primary diagnosis of panic disorder with or without agoraphobia.
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Schwarz, C. M., & Holsinger, T. (2022). A Randomized Controlled Study of Paroxetine and Cognitive Behavioral Therapy for Late-Life Panic Disorder. In Essential Reviews in Geriatric Psychiatry (pp. 79–82). https://doi.org/10.1007/978-3-030-94960-0_14
Schwarz, C. M., and T. Holsinger. “A Randomized Controlled Study of Paroxetine and Cognitive Behavioral Therapy for Late-Life Panic Disorder.” In Essential Reviews in Geriatric Psychiatry, 79–82, 2022. https://doi.org/10.1007/978-3-030-94960-0_14.
Schwarz CM, Holsinger T. A Randomized Controlled Study of Paroxetine and Cognitive Behavioral Therapy for Late-Life Panic Disorder. In: Essential Reviews in Geriatric Psychiatry. 2022. p. 79–82.
Schwarz, C. M., and T. Holsinger. “A Randomized Controlled Study of Paroxetine and Cognitive Behavioral Therapy for Late-Life Panic Disorder.” Essential Reviews in Geriatric Psychiatry, 2022, pp. 79–82. Scopus, doi:10.1007/978-3-030-94960-0_14.
Schwarz CM, Holsinger T. A Randomized Controlled Study of Paroxetine and Cognitive Behavioral Therapy for Late-Life Panic Disorder. Essential Reviews in Geriatric Psychiatry. 2022. p. 79–82.